22. July 2015

IPEC calls on FDA to establish new review process for novel excipients

By Zachary Brennan+, 22-Jul-2015

As part of a push to bring more novel excipients to market, IPEC-Americas is calling on the FDA to create a new regulatory review process that could relieve some of the uncertainty around the use of new excipients.

Tags: excipient, IPEC, novel, fda, jul2015

IPEC calls on FDA to establish new review process for novel excipients

Paliperidone ascending controlled-release pellets with osmotic core and driven by delayed osmotic pressure

Conformational polymorphic changes in the crystal structure of the chiral antiparasitic drug praziquantel and interactions with calcium carbonate

An investigation into the release behavior of solid lipid microparticles in different simulated gastrointestinal fluids